Award

Delineating the p62 oligomerization-mediated muscle adaptation to exercise in heart failure-induced skeletal myopathy

Description: Myopathy is a serious complication of heart failure (HF) associated with a poor prognosis. Exercise training acts as a therapy for HF-induced myopathy. Muscle is central to this adaptive effect, but underlying mechanisms are poorly understood. Reactive oxygen species and particularly cysteine oxidation supposedly play important roles in mediating beneficial exercise-induced adaptations in skeletal muscle. Deploying our newly developed redox proteomics technology in human muscle samples after exercise, we mapped for the first time the whole landscape of proteins regulated by redox signaling. Among the cysteines reproducibly undergoing the most pronounced redox modification induced by exercise is Cysteine 113 of the pivotal autophagy protein SQSTM1 (p62) (p62C113). The general hypothesis underlying this proposal is that exercise-induced changes in redox-sensitive proteins can be exploited for devising novel therapies against HF-associated muscle wasting. Specifically, we aim to A) determine the role of redox-regulated p62C113 in autophagy and delineate the upstream and downstream underlying molecular mechanisms; B) investigate the importance of p62C113-mediated autophagy for muscle adaptation in heart failure-induced skeletal myopathy. Preliminary data in an in vitro exercise model show that (i) Exercise-induced oxidation of p62 C113 modulates p62 oligomerization and (ii) Exercise-induced p62 oligomerization regulates autophagy in a p62C113-dependent way. Given that autophagy plays an essential role in muscle adaptation, especially glucose metabolism during exercise, these results provide strong conceptual support that exercise-induced p62 oligomerization regulates muscle adaptation via autophagy. Next to in vitro cell study, a novel mouse model of p62C113S point mutation will be used to determine if improvement of HF-induced myopathy by exercise depends on Cystine 113. Taken together, the results of this project will conceivably increase our mechanistic understanding of muscle remodeling in response to exercise and thereby lead to the definition of novel intervention targets against HF skeletal myopathy and other muscle wasting disease, such as sarcopenia and cancer cachexia. We are willing to share overview information about this proposal, including name, institution, project title, project summary, and summary for non-scientists.
Amount: $165,900
Funding type: fellowship
Funder scheme: Postdoctoral Fellowship
Start date: 2025-01-01
End date: 2026-12-31
Investigator: Yu Lei (lead)
Funded outputs count: 1
Funder award ID: 25POST1376679
OpenAlex ID: G5339538127
2026 · Yu Lei, Jonathan J. Petrocelli, et al. · bioRxiv (Cold Spring Harbor Laboratory)